Eurofins' Food and Feed Testing segment provides comprehensive analytical services to ensure the safety, quality, and compliance of food and animal feed products. This includes allergen testing, GMO analysis, grain quality assessment, meat speciation, nanomaterial detection, pesticide residue analysis, and residual DNA testing. The segment employs advanced technologies such as chromatography, mass spectrometry, and molecular biology to detect contaminants, verify authenticity, and ensure nutritional content. R&D efforts focus on developing rapid and cost-effective testing methods, improving detection limits, and expanding the range of analytes covered. This segment supports food manufacturers, retailers, and regulatory agencies in safeguarding public health and maintaining consumer trust. Future opportunities include expanding services to address emerging food safety concerns and leveraging data analytics to provide predictive insights.

The Environment Testing segment offers a wide array of analytical services to assess the quality of water, air, soil, and waste. Eurofins utilizes sophisticated techniques like gas chromatography-mass spectrometry (GC-MS), inductively coupled plasma mass spectrometry (ICP-MS), and high-performance liquid chromatography (HPLC) to detect pollutants, measure contaminants, and ensure regulatory compliance. Research and development efforts are directed towards enhancing the sensitivity and accuracy of testing methods, developing innovative sampling techniques, and addressing emerging environmental challenges such as microplastics and PFAS. This segment supports environmental agencies, industrial clients, and municipalities in monitoring environmental conditions, remediating contaminated sites, and protecting natural resources. Future growth potential lies in expanding services related to climate change monitoring, sustainable agriculture, and waste management.

Eurofins' Pharmaceutical Testing segment provides comprehensive analytical services to support drug development, manufacturing, and quality control. This includes testing raw materials, active pharmaceutical ingredients (APIs), finished products, and packaging materials. The segment employs advanced analytical techniques such as chromatography, mass spectrometry, and spectroscopy to ensure the identity, purity, potency, and safety of pharmaceutical products. R&D efforts focus on developing new analytical methods, improving detection limits, and addressing emerging regulatory requirements. This segment supports pharmaceutical companies, biotechnology firms, and contract manufacturing organizations (CMOs) in ensuring the quality and compliance of their products. Future opportunities include expanding services related to biologics, biosimilars, and personalized medicine.